全文获取类型
收费全文 | 2393052篇 |
免费 | 181468篇 |
国内免费 | 4076篇 |
专业分类
耳鼻咽喉 | 34453篇 |
儿科学 | 72827篇 |
妇产科学 | 62929篇 |
基础医学 | 335263篇 |
口腔科学 | 67610篇 |
临床医学 | 215958篇 |
内科学 | 469793篇 |
皮肤病学 | 48041篇 |
神经病学 | 201455篇 |
特种医学 | 96054篇 |
外国民族医学 | 886篇 |
外科学 | 360740篇 |
综合类 | 56223篇 |
现状与发展 | 1篇 |
一般理论 | 978篇 |
预防医学 | 190838篇 |
眼科学 | 55583篇 |
药学 | 177768篇 |
56篇 | |
中国医学 | 4370篇 |
肿瘤学 | 126770篇 |
出版年
2018年 | 24288篇 |
2016年 | 20706篇 |
2015年 | 23298篇 |
2014年 | 33551篇 |
2013年 | 50835篇 |
2012年 | 68733篇 |
2011年 | 72276篇 |
2010年 | 42475篇 |
2009年 | 40861篇 |
2008年 | 68755篇 |
2007年 | 73099篇 |
2006年 | 73997篇 |
2005年 | 72032篇 |
2004年 | 69335篇 |
2003年 | 67010篇 |
2002年 | 66257篇 |
2001年 | 112449篇 |
2000年 | 116526篇 |
1999年 | 98332篇 |
1998年 | 27858篇 |
1997年 | 25522篇 |
1996年 | 25447篇 |
1995年 | 24609篇 |
1994年 | 23159篇 |
1993年 | 21553篇 |
1992年 | 79388篇 |
1991年 | 76395篇 |
1990年 | 73576篇 |
1989年 | 70842篇 |
1988年 | 65846篇 |
1987年 | 64800篇 |
1986年 | 61336篇 |
1985年 | 58400篇 |
1984年 | 44223篇 |
1983年 | 37659篇 |
1982年 | 22886篇 |
1981年 | 20332篇 |
1980年 | 19034篇 |
1979年 | 41299篇 |
1978年 | 28986篇 |
1977年 | 24346篇 |
1976年 | 22832篇 |
1975年 | 23965篇 |
1974年 | 29639篇 |
1973年 | 28042篇 |
1972年 | 26226篇 |
1971年 | 24151篇 |
1970年 | 22752篇 |
1969年 | 21088篇 |
1968年 | 19135篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Edward J.A. Harris Steven Kao Brian McCaughan Takashi Nakano Nobuyuki Kondo Rebecca Hyland Anna K. Nowak Nicholas H. de Klerk Fraser J.H. Brims 《Journal of thoracic oncology》2019,14(2):288-293
Introduction
Malignant pleural mesothelioma (MPM) is an uncommon cancer with a poor prognosis and heterogeneous survival. Surgery for MPM is offered in some specialist centers to highly selected patients. A previously described classification and regression tree (CART) model stratified survival in unselected MPM patients using routinely collected clinical data. This study aimed to examine the performance of this CART model on a highly selected surgical population.Methods
Data were collected from subjects undergoing cytoreductive surgery for MPM from specialist centers in Hyõgo, Japan, and Sydney, Australia, between 1991 and 2016. The CART model was applied using the combination of clinical variables to stratify subjects into risk groups (1 through 4); survival characteristics were then compared.Results
Two hundred eighty-nine cases were included (205 from Australia, 84 from Japan). Overall median survival was 34.6 (interquartile range: 17.5–56.1) months; median age was 63.0 (interquartile range: 57.0–67.8) years, and 83.0% (n = 240) were male. There were no clinically meaningful differences between the two cohorts. Survival across the four risk groups was significantly different (p < 0.0001); the model stratified survival well with a Harrell's concordance statistic of 0.62 (95% confidence interval: 0.57–0.66) at 36 months. The group with the longest survival (median, 82.5 months) had: no weight loss, hemoglobin > 153 g/L and serum albumin > 43 g/L at time of referral to the surgical center.Conclusions
Using routinely available clinical variables, the CART model was able to stratify surgical patients into risk groups with statistically different survival characteristics with fair to good performance. Presence of weight loss, anemia, and low albumin should confer caution when considering surgical therapy for MPM. 相似文献52.
Gregory Lazarian Shanye Yin Elisa ten Hacken Tomasz Sewastianik Mohamed Uduman Alba Font-Tello Satyen H. Gohil Shuqiang Li Ekaterina Kim Heather Joyal Leah Billington Elizabeth Witten Mei Zheng Teddy Huang Mariano Severgnini Valerie Lefebvre Laura Z. Rassenti Catherine Gutierrez Catherine J. Wu 《Cancer cell》2021,39(3):380-393.e8
- Download : Download high-res image (201KB)
- Download : Download full-size image
53.
54.
55.
56.
57.
58.
Cost‐Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States
下载免费PDF全文

59.
There is keen interest in many jurisdictions in finding ways to improve the way that research evidence informs policy. One possible mechanism for this is to embed academics within government agencies either as advisers or full staff members. Our commentary argues that, in addition to considering the role of academics in government as proposed by Glied and colleagues, we need to understand better how research and policy interactions function across policy sectors. We believe more comparative research is needed to understand if and why academics from certain disciplines are more likely to be recruited to work in some policy sectors rather than others. We caution against treating government as monolithic by advocating the same model for collaborative interaction between academics and government. Lastly, we contend that contextualized research is needed to illuminate important drivers of research and policy interactions before we can recommend what is likely to be more and less effective in different policy sectors. 相似文献
60.
Lisa I. Iezzoni Amy J. Wint Alexy Arauz Boudreau Cheri A. Blauwet Karen A. Kuhlthau 《Disability and health journal》2018,11(3):405-411